Register Now for NAAF's 39th Annual Patient Conference June 27-30, 2024 in Washington, D.C.!

Research

FDA Accepts Filing of New Drug Application (NDA)

Today we received the welcome news that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug…

FDA Approves Olumiant™ (baricitinib) for Adults with Severe Alopecia Areata

Today, history was made as the U.S. Food and Drug Administration (FDA) approved Olumiant™ for alopecia areata, marking the first…